3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Carcinoma, Hepatocellular
3
Small Cell Lung Carcinoma
2
Glioblastoma
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stage III Lung Non-Small Cell Cancer AJCC v7
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Sarcoma
1
Melanoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Liver Cirrhosis
1
Gliosarcoma
1
Glioma
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Astrocytoma
1
Interventions
Temozolomide
37
Radiotherapy
20
Bevacizumab
14
Carboplatin
10
Magnetic Resonance Spectroscopy
9
Carmustine
9
antineoplaston AS 2-1
8
antineoplaston A10
8
Irinotecan
8
Filgrastim
7
Cyclophosphamide
6
Cisplatin
6
Etoposide
5
sargramostim
4
Vincristine
4
Thiotepa
4
Surgical Procedures, Operative
4
Specimen Handling
4
Radiation
4
Peripheral Blood Stem Cell Transplantation
4
Lomustine
4
Everolimus
4
Chemotherapy, Adjuvant
4
trametinib
3
aldesleukin
3
Topotecan
3
Thalidomide
3
Tamoxifen
3
Sunitinib
3
Procarbazine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Astrocytoma
×
fluoromisonidazole
×
Clear all
NCT01868906
2018-08-24
FMISOPETSCS
Dr. Negrin University Hospital
Phase 2
Terminated
6 enrolled